These compounds offer distinct advantages over their peptide-based counterparts, including oral bioavailability, improved patient adherence, and the potential for broader therapeutic applications
Wegovy, Ozempic, Rybelsus (Semaglutide) 5% 10%
Who qualifies for Foundayo BMI and weight requirements Foundayo is FDA-approved for adults with obesity (BMI of 30 or higher) or adults with overweight (BMI of 27 or higher) who have at least one weight-related health condition
One pathway strong enough
Published peer-reviewed studies include research on transected Achilles tendons in rats, quadriceps muscle crush injury models, surgically-induced and chemically-induced gastrointestinal lesions, NSAID-induced mucosal damage models, and ligament transection recovery studies
Medicaid accounted for less than 10% of semaglutide fills for all three drug brands in 2023